Erratum To: Pharmacology of Anticoagulants Used in the Treatment of Venous Thromboembolism

Journal of Thrombosis and Thrombolysis - Netherlands
doi 10.1007/s11239-016-1363-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Treatment of Venous Thromboembolism With New Oral Anticoagulants

Italian Journal of Medicine
Medicine
2013English

Anticoagulants in Venous Thromboembolism.

BMJ
1989English

Recent Advances in the Treatment of Venous Thromboembolism in the Era of the Direct Oral Anticoagulants

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Development of Treatment of Cancer-Associated Venous Thromboembolism With Direct Oral Anticoagulants

The Japanese Journal of Phlebology
2020English

New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities

Drugs
Pharmacology
2014English

Pcv138 - Treatment Patterns of Patients With Venous Thromboembolism Treated With Oral Anticoagulants in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Potential Role of New Anticoagulants for Prevention and Treatment of Venous Thromboembolism in Cancer Patients

Vascular Health and Risk Management
2013English

Derivation of the Non-Inferiority Margin for the Evaluation of Direct Oral Anticoagulants in the Treatment of Venous Thromboembolism

Thrombosis Journal
Hematology
2013English

Hypoalbuminemia for the Prediction of Venous Thromboembolism and Treatment of Direct Oral Anticoagulants in Metastatic Gastric Cancer Patients

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy